China Independent Clinical Laboratory Market Outlook to 2018 - Escalating Significance of Diagnostic Tests to Impel Growth
The report titled “China Independent Clinical Laboratory Market Outlook to 2018 - Escalating Significance of Diagnostic Tests to Impel Growth” provides a comprehensive analysis of the market size of the Independent Clinical Labs Industry in China. Industry has been segmented on the basis of services offered by the labs and expenditure incurred on the equipments. The report also entails the market share and company profiles of the major players in the China Independent Clinical Laboratory industry. An analysis of the future of Independent Clinical Laboratory market in China is provided on the basis of revenue of the market over next five years.
The China independent clinical laboratory market revenue by services has grown at a CAGR of 45.0% which has increased from USD ~ million in 2008 to USD ~ million in 2013. Increasing incidences of lifestyle diseases, mounting health awareness, growing consolidations and strategic partnership, accreditation of laboratories, rapid urbanization, increasing number of laboratories and the overall improvement in the medical infrastructure are some of the major factors responsible for the growth of independent clinical labs market showcased over the last 6 years.
Market growth was primarily led by the immunology, biochemistry and hematology segments. The highest contribution to the revenues was contributed by the immunology market, followed by the revenues from the biochemistry market.
The versatility of diseases and the increasing frequency of diagnostic tests have driven the market of independent clinical laboratory equipments in China. The expenditure incurred by nearly 8000 anatomical labs in China on equipments has grown at the CAGR of 25.1%; having increased from USD ~ million in 2008 to USD ~million in 2013. With the growth of health care technology, the expenditure incurred by the laboratories on equipments has continued to grow over the past 5 years.
Independent clinical laboratory equipments include Cervical cytology, Pre-staining histology, Microscopy and Routine/IHC staining. Cervical cytology accounted for the majority share of ~% in total independent lab expenditure on equipments in 2013 followed by Pre-staining histology with ~% share in the same year.
Independent clinical laboratory industry in China is poised to grow gradually and steadily in the coming 5 years. Its steady growth will be driven by an extensive consumer base. Streamlined distribution network has made diagnostic services easily accessible in various regions. An increase in the number of pathology laboratories and inclining number of hospitals, both in the public and the private sector will result in the enhancement of the overall healthcare infrastructure. Consequently, easier accessibility of healthcare will provide a significant thrust to the diagnostic service market in China. . It is anticipated that the independent clinical laboratory revenue will reach USD 3,369.2 million by 2018 by growing at a CAGR of 45.9% during the period 2013-2018.
KEY TOPICS COVERED IN THE REPORT
The China independent clinical laboratory market revenue by services has grown at a CAGR of 45.0% which has increased from USD ~ million in 2008 to USD ~ million in 2013. Increasing incidences of lifestyle diseases, mounting health awareness, growing consolidations and strategic partnership, accreditation of laboratories, rapid urbanization, increasing number of laboratories and the overall improvement in the medical infrastructure are some of the major factors responsible for the growth of independent clinical labs market showcased over the last 6 years.
Market growth was primarily led by the immunology, biochemistry and hematology segments. The highest contribution to the revenues was contributed by the immunology market, followed by the revenues from the biochemistry market.
The versatility of diseases and the increasing frequency of diagnostic tests have driven the market of independent clinical laboratory equipments in China. The expenditure incurred by nearly 8000 anatomical labs in China on equipments has grown at the CAGR of 25.1%; having increased from USD ~ million in 2008 to USD ~million in 2013. With the growth of health care technology, the expenditure incurred by the laboratories on equipments has continued to grow over the past 5 years.
Independent clinical laboratory equipments include Cervical cytology, Pre-staining histology, Microscopy and Routine/IHC staining. Cervical cytology accounted for the majority share of ~% in total independent lab expenditure on equipments in 2013 followed by Pre-staining histology with ~% share in the same year.
Independent clinical laboratory industry in China is poised to grow gradually and steadily in the coming 5 years. Its steady growth will be driven by an extensive consumer base. Streamlined distribution network has made diagnostic services easily accessible in various regions. An increase in the number of pathology laboratories and inclining number of hospitals, both in the public and the private sector will result in the enhancement of the overall healthcare infrastructure. Consequently, easier accessibility of healthcare will provide a significant thrust to the diagnostic service market in China. . It is anticipated that the independent clinical laboratory revenue will reach USD 3,369.2 million by 2018 by growing at a CAGR of 45.9% during the period 2013-2018.
KEY TOPICS COVERED IN THE REPORT
- The market size of the China Independent Clinical Labs Industry on the basis of Revenue Earned through Services, 2008-2013
- The market size of the China Independent Clinical Labs Industry on the basis of Expenditure Incurred on Equipments, 2008-2013
- Market segmentation of China Independent Clinical Labs Industry by services
- Market segmentation of China Independent Clinical Labs Industry by expenditure on equipments, 2008-2013
- Growth Drivers for the China Independent Clinical Labs Industry
- Recent Industry Activities in China Independent Clinical Labs Industry
- Market Share of Major Players in China Independent Clinical Labs Industry
- Company profiles of major players in the China Independent Clinical Labs Industry
- Future outlook and projections on the basis of revenue in China Independent Clinical Labs Industry, 2014-2018
1. CHINA INDEPENDENT CLINICAL LABS MARKET INTRODUCTION
1.1. Organizational Structure of Clinical Labs Market in China, 2013
2. CHINA INDEPENDENT CLINICAL LABS MARKET SIZE
2.1. By Revenue Earned through Services, 2008-2013
2.2. By Expenditure Incurred on Equipments, 2008-2013
3. CHINA INDEPENDENT CLINICAL LABS MARKET SEGMENTATION
3.1. By Expenditure Incurred on Equipments, 2011-2013
3.2. Different Types of Services Offered in Clinical Labs in China
4. GROWTH DRIVERS OF CHINA INDEPENDENT CLINICAL LABS MARKET
High Cost For Establishing Medical Laboratory
Escalating Significance of Laboratory Tests in Clinical Practice
Improving Healthcare Infrastructure
Mounting Prevalence of Lifestyle Diseases and Aging Population
Augmenting Purchasing Power and Mounting Health Consciousness
Advantages of Independent Clinical Laboratories over Hospital Clinical Laboratories
5. MAJOR CHALLENGES OF CHINA INDEPENDENT CLINICAL LABS MARKET
Lower Rural Penetration
Higher Equipment Costs
Lack of Standardization
6. COMPANY PROFILES OF MAJOR PLAYERS IN INDEPENDENT CLINICAL LABS MARKET IN CHINA
6.1. Kingmed Diagnostics
6.1.1. Company Overview
6.1.2. Business Strategies
Expansion and Development of New Test Services
Collaboration with other Healthcare Organizations and Agencies
Focus in Maintaining Quality Systems in KingMed
6.1.3. Product Portfolio
6.1.4. Financial Performance, 2008-2014
6.2. Hangzhou Adicon
6.2.1. Company Overview
6.2.2. Business Strategies
Expanding the Number of Labs and Test Services in China
Strategic Partnership with International Companies
6.2.3. Product Portfolio
6.2.4. Financial Performance, 2010-2013
6.3. Zhejiang Dian Diagnostics Technology Co. Ltd.
6.3.1. Company Overview
6.3.2. Business Strategies
Focus on Research and Development and Technological Innovation
Strategic Partnerships and Collaborations
6.3.3. Product Portfolio
6.3.4. Financial Performance, 2008-2013
6.4. DAAN Gene
6.4.1. Company Overview
6.4.2. Business Strategies
Focus on Research and Development
Alliances and Partnerships
6.4.3. Product Portfolio
6.4.4. Financial Performance, 2008-2013
6.5. Kindstar Global Diagnostics Co. Ltd
6.5.1. Company Overview
6.5.2. Business Strategies
Partnerships and Strategic Collaborative Agreements
Use of Leading-Edge Technology
6.5.3. Product Portfolio
6.5.4. Financial Performance, 2010 and 2013
Revenue Structure Based on Test Service Type
7. MARKET SHARE OF MAJOR PLAYERS IN CHINA INDEPENDENT CLINICAL LABS INDUSTRY, 2013
8. RECENT INDUSTRY ACTIVITIES IN CHINA INDEPENDENT CLINICAL LABS MARKET
9. QUALITY MANAGERIAL SYSTEM IN INDEPENDENT CLINICAL LABS IN CHINA
China National Accreditation Service for Conformity Assessment (CNAS)
Implementation of ISO 15189 in Clinical Laboratories in China
The Characteristics of Independent Clinical Laboratory Quality Managerial System in China
Benefits of Accreditation
10. CHINA INDEPENDENT CLINICAL LABS MARKET FUTURE OUTLOOK AND PROJECTIONS, 2014-2018
Base Scenario
Conservative Scenario
Aggressive Scenario
10.1. Cause and Effect Relationship between Dependent and Independent Factors Prevailing In Independent Clinical Labs Industry in China
11. MACROECONOMIC AND INDUSTRY FACTORS
11.1. Population in China, 2008-2018
11.2. Disposable Income Per Capita in China, 2008-2018
11.3. Private Expenditure on Healthcare Sector in China, 2008-2018
11.4. Public Expenditure on Healthcare Sector in China, 2008-2018
11.5. Number of Clinical Laboratories in China, 2008-2018
12. APPENDIX
12.1. Market Definition
12.2. Market Abbreviations
12.3. Research Methodology
Data Collection Methods
Approach
Variables (Dependent and Independent)
Multi Factor Based Sensitivity Model
Final Conclusion
12.4. Disclaimer
1.1. Organizational Structure of Clinical Labs Market in China, 2013
2. CHINA INDEPENDENT CLINICAL LABS MARKET SIZE
2.1. By Revenue Earned through Services, 2008-2013
2.2. By Expenditure Incurred on Equipments, 2008-2013
3. CHINA INDEPENDENT CLINICAL LABS MARKET SEGMENTATION
3.1. By Expenditure Incurred on Equipments, 2011-2013
3.2. Different Types of Services Offered in Clinical Labs in China
4. GROWTH DRIVERS OF CHINA INDEPENDENT CLINICAL LABS MARKET
High Cost For Establishing Medical Laboratory
Escalating Significance of Laboratory Tests in Clinical Practice
Improving Healthcare Infrastructure
Mounting Prevalence of Lifestyle Diseases and Aging Population
Augmenting Purchasing Power and Mounting Health Consciousness
Advantages of Independent Clinical Laboratories over Hospital Clinical Laboratories
5. MAJOR CHALLENGES OF CHINA INDEPENDENT CLINICAL LABS MARKET
Lower Rural Penetration
Higher Equipment Costs
Lack of Standardization
6. COMPANY PROFILES OF MAJOR PLAYERS IN INDEPENDENT CLINICAL LABS MARKET IN CHINA
6.1. Kingmed Diagnostics
6.1.1. Company Overview
6.1.2. Business Strategies
Expansion and Development of New Test Services
Collaboration with other Healthcare Organizations and Agencies
Focus in Maintaining Quality Systems in KingMed
6.1.3. Product Portfolio
6.1.4. Financial Performance, 2008-2014
6.2. Hangzhou Adicon
6.2.1. Company Overview
6.2.2. Business Strategies
Expanding the Number of Labs and Test Services in China
Strategic Partnership with International Companies
6.2.3. Product Portfolio
6.2.4. Financial Performance, 2010-2013
6.3. Zhejiang Dian Diagnostics Technology Co. Ltd.
6.3.1. Company Overview
6.3.2. Business Strategies
Focus on Research and Development and Technological Innovation
Strategic Partnerships and Collaborations
6.3.3. Product Portfolio
6.3.4. Financial Performance, 2008-2013
6.4. DAAN Gene
6.4.1. Company Overview
6.4.2. Business Strategies
Focus on Research and Development
Alliances and Partnerships
6.4.3. Product Portfolio
6.4.4. Financial Performance, 2008-2013
6.5. Kindstar Global Diagnostics Co. Ltd
6.5.1. Company Overview
6.5.2. Business Strategies
Partnerships and Strategic Collaborative Agreements
Use of Leading-Edge Technology
6.5.3. Product Portfolio
6.5.4. Financial Performance, 2010 and 2013
Revenue Structure Based on Test Service Type
7. MARKET SHARE OF MAJOR PLAYERS IN CHINA INDEPENDENT CLINICAL LABS INDUSTRY, 2013
8. RECENT INDUSTRY ACTIVITIES IN CHINA INDEPENDENT CLINICAL LABS MARKET
9. QUALITY MANAGERIAL SYSTEM IN INDEPENDENT CLINICAL LABS IN CHINA
China National Accreditation Service for Conformity Assessment (CNAS)
Implementation of ISO 15189 in Clinical Laboratories in China
The Characteristics of Independent Clinical Laboratory Quality Managerial System in China
Benefits of Accreditation
10. CHINA INDEPENDENT CLINICAL LABS MARKET FUTURE OUTLOOK AND PROJECTIONS, 2014-2018
Base Scenario
Conservative Scenario
Aggressive Scenario
10.1. Cause and Effect Relationship between Dependent and Independent Factors Prevailing In Independent Clinical Labs Industry in China
11. MACROECONOMIC AND INDUSTRY FACTORS
11.1. Population in China, 2008-2018
11.2. Disposable Income Per Capita in China, 2008-2018
11.3. Private Expenditure on Healthcare Sector in China, 2008-2018
11.4. Public Expenditure on Healthcare Sector in China, 2008-2018
11.5. Number of Clinical Laboratories in China, 2008-2018
12. APPENDIX
12.1. Market Definition
12.2. Market Abbreviations
12.3. Research Methodology
Data Collection Methods
Approach
Variables (Dependent and Independent)
Multi Factor Based Sensitivity Model
Final Conclusion
12.4. Disclaimer
LIST OF FIGURES
Figure 1: China Clinical Laboratory Market Segmentation by Hospital Labs and Independent Labs in Percentage (%), 2013
Figure 2: China Independent Clinical Laboratory Market Size on the Basis of Revenue from Services in USD Million, 2008-2013
Figure 3: China Independent Clinical Laboratory Market Size on the Basis of Expenditure Incurred on Equipments in USD Million, 2008-2013
Figure 4: China Independent Clinical Labs Market Segmentation by Types of Equipments on the Basis of Expenditure Contribution in Percentage (%), 2011-2013
Figure 5: Kingmed Diagnostics Revenue in USD Million, 2008-2014
Figure 6: Hangzhou Adicon Revenue in USD Million, 2010-2013
Figure 7: Dian Diagnostics Revenue Structure by Diagnostic Services and Diagnostic Products on the Basis of Revenue in Percentage (%), 2013
Figure 8: Dian Diagnostics Revenue from Clinical Testing Services in USD Million, 2008-2013
Figure 9: DAAN Gene’s Total Revenue in USD Million, 2008-2013
Figure 10: DAAN Gene’s Revenue from Test Services in USD Million, 2010-2013
Figure 11: Kindstar Global Diagnostics Co. Ltd Revenue in USD Million, 2010 and 2013
Figure 12: Kindstar Collaboration with the Number of Hospitals, 2006-2012
Figure 13: Kindstar Global Revenue Structure by Esoteric and General Tests on the Basis of Revenue in Percentage (%), 2013
Figure 14: Market Share of Major Laboratories in China Independent Clinical Laboratory Industry on the Basis of Revenue in Percentage (%), 2013
Figure 15: Independent Clinical Laboratory Industry Projections in Terms of Revenue from Services in USD Million, 2014-2018
Figure 16: Population in China in Million, 2008-2018
Figure 17: China Population (65 Years and Above) in Million, 2008-2018
Figure 18: Disposable Income Per Capita in China in USD, 2008-2018
Figure 19: Private Expenditure on Healthcare Sector in China in USD Million, 2008-2018
Figure 20: Public Expenditure on Healthcare Sector in China in USD Million, 2008-2018
Figure 21: Number of Clinical Laboratories in China, 2008-2018
Figure 1: China Clinical Laboratory Market Segmentation by Hospital Labs and Independent Labs in Percentage (%), 2013
Figure 2: China Independent Clinical Laboratory Market Size on the Basis of Revenue from Services in USD Million, 2008-2013
Figure 3: China Independent Clinical Laboratory Market Size on the Basis of Expenditure Incurred on Equipments in USD Million, 2008-2013
Figure 4: China Independent Clinical Labs Market Segmentation by Types of Equipments on the Basis of Expenditure Contribution in Percentage (%), 2011-2013
Figure 5: Kingmed Diagnostics Revenue in USD Million, 2008-2014
Figure 6: Hangzhou Adicon Revenue in USD Million, 2010-2013
Figure 7: Dian Diagnostics Revenue Structure by Diagnostic Services and Diagnostic Products on the Basis of Revenue in Percentage (%), 2013
Figure 8: Dian Diagnostics Revenue from Clinical Testing Services in USD Million, 2008-2013
Figure 9: DAAN Gene’s Total Revenue in USD Million, 2008-2013
Figure 10: DAAN Gene’s Revenue from Test Services in USD Million, 2010-2013
Figure 11: Kindstar Global Diagnostics Co. Ltd Revenue in USD Million, 2010 and 2013
Figure 12: Kindstar Collaboration with the Number of Hospitals, 2006-2012
Figure 13: Kindstar Global Revenue Structure by Esoteric and General Tests on the Basis of Revenue in Percentage (%), 2013
Figure 14: Market Share of Major Laboratories in China Independent Clinical Laboratory Industry on the Basis of Revenue in Percentage (%), 2013
Figure 15: Independent Clinical Laboratory Industry Projections in Terms of Revenue from Services in USD Million, 2014-2018
Figure 16: Population in China in Million, 2008-2018
Figure 17: China Population (65 Years and Above) in Million, 2008-2018
Figure 18: Disposable Income Per Capita in China in USD, 2008-2018
Figure 19: Private Expenditure on Healthcare Sector in China in USD Million, 2008-2018
Figure 20: Public Expenditure on Healthcare Sector in China in USD Million, 2008-2018
Figure 21: Number of Clinical Laboratories in China, 2008-2018
LIST OF TABLES
Table 1: China Clinical Laboratory Market Segmentation on the Basis of Number of Hospital Labs and Independent Labs in China, 2013
Table 2: China Independent Clinical Labs Market Segmentation by Types of Equipments on the Basis of Expenditure in USD Million, 2011-2013
Table 3: Comparison of Testing Capacities of Kingmed Diagnostics in Mainland China in 2011
Table 4: Comparison of Testing Capacities of Adicon and Dian Diagnostics in Mainland China in 2011
Table 5: Timeline of Kingmed Diagnostics from 1994-2013
Table 6: Kingmed Diagnostics Portfolio of Services Offered
Table 7: Timeline of Hangzhou Adicon from 2004-2010
Table 8: Hangzhou Adicon Portfolio of Test Items
Table 9: Timeline of Dian Diagnostics from 2001-2012
Table 10: Zhejiang Dian Diagnostics Co. Ltd. Portfolio of Services
Table 11: DAAN Gene Portfolio of Products Offered
Table 12: Timeline of Kindstar Global Diagnostics Co. Ltd from 2004-2012
Table 13: Kindstar Global Diagnostics Co. Ltd Portfolio of Test Services
Table 14: Revenue of Major Laboratories in Independent Clinical Laboratory Industry in China in USD million, 2013
Table 15: Recent Industry Activities in Independent Clinical Laboratory Industry in China
Table 16: Testing capacities of Independent Medical Labs Accredited by CAP-LAP in China
Table 17: Independent Clinical Laboratory Industry Projections in Terms of Revenue from Services in USD Million, 2014-2018
Table 18: Cause and Effect Relationship Analysis between Industry Factors and Expected Prospects in Independent Clinical Laboratory Industry in China
Table 19: China Population Segmentation on the Basis of People Residing in Urban and Rural Areas in Million, 2008-2013
Table 20: Correlation Matrix of China Independent Clinical Laboratory Industry
Table 21: Regression Coefficients Output
Table 1: China Clinical Laboratory Market Segmentation on the Basis of Number of Hospital Labs and Independent Labs in China, 2013
Table 2: China Independent Clinical Labs Market Segmentation by Types of Equipments on the Basis of Expenditure in USD Million, 2011-2013
Table 3: Comparison of Testing Capacities of Kingmed Diagnostics in Mainland China in 2011
Table 4: Comparison of Testing Capacities of Adicon and Dian Diagnostics in Mainland China in 2011
Table 5: Timeline of Kingmed Diagnostics from 1994-2013
Table 6: Kingmed Diagnostics Portfolio of Services Offered
Table 7: Timeline of Hangzhou Adicon from 2004-2010
Table 8: Hangzhou Adicon Portfolio of Test Items
Table 9: Timeline of Dian Diagnostics from 2001-2012
Table 10: Zhejiang Dian Diagnostics Co. Ltd. Portfolio of Services
Table 11: DAAN Gene Portfolio of Products Offered
Table 12: Timeline of Kindstar Global Diagnostics Co. Ltd from 2004-2012
Table 13: Kindstar Global Diagnostics Co. Ltd Portfolio of Test Services
Table 14: Revenue of Major Laboratories in Independent Clinical Laboratory Industry in China in USD million, 2013
Table 15: Recent Industry Activities in Independent Clinical Laboratory Industry in China
Table 16: Testing capacities of Independent Medical Labs Accredited by CAP-LAP in China
Table 17: Independent Clinical Laboratory Industry Projections in Terms of Revenue from Services in USD Million, 2014-2018
Table 18: Cause and Effect Relationship Analysis between Industry Factors and Expected Prospects in Independent Clinical Laboratory Industry in China
Table 19: China Population Segmentation on the Basis of People Residing in Urban and Rural Areas in Million, 2008-2013
Table 20: Correlation Matrix of China Independent Clinical Laboratory Industry
Table 21: Regression Coefficients Output
